Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

EGF Theramed Health Corp C.TMED

Alternate Symbol(s):  EVAHF

EGF Theramed Health Corp. is a Canada-based company engaged in developing products, technologies, and diagnostic tools focused on personalized medical care, including research into natural health and wellness products. The Company is focused on the psilocybin space, looking at methods of improving delivery systems for the compound. The Company explores many other medical areas, including weight loss, skin care and heart disease. Its portfolio includes Pharmadelic Labs and Green Parrot Labs. Pharmadelic Labs is a biotech company focusing on improving and patenting engineering processes for the biosynthesis of compounds - primarily psilocybin, the psychoactive component of magic mushrooms. Green Parrot Labs is a Caribbean-based company focusing on research into psilocybin and establishing health centers dealing with treatment-resistant conditions. The Company is also actively exploring opportunities in all medical areas in domestic and international markets.


CSE:TMED - Post by User

Post by Ventrueon Apr 04, 2023 10:02pm
298 Views
Post# 35380153

Who wants to talk?

Who wants to talk?people lurking but no one weighing in.  If the folks are in fact shopping for distressed assets, what's the feeling?  Was the runup just a few buyers catching old shareholders not wtching? Anyone got any IR intel? Surely someone has heard something . . . 

With the rollback, this should be easy to get rocking
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities